Clear Harbor Asset Management LLC Has $4.49 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Clear Harbor Asset Management LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,867 shares of the healthcare conglomerate’s stock after acquiring an additional 359 shares during the period. Clear Harbor Asset Management LLC’s holdings in UnitedHealth Group were worth $4,485,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Segment Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 1.8% during the 4th quarter. Segment Wealth Management LLC now owns 30,746 shares of the healthcare conglomerate’s stock valued at $15,553,000 after purchasing an additional 547 shares in the last quarter. Charles Schwab Trust Co boosted its holdings in shares of UnitedHealth Group by 14.7% in the fourth quarter. Charles Schwab Trust Co now owns 771 shares of the healthcare conglomerate’s stock valued at $390,000 after buying an additional 99 shares during the period. Lmcg Investments LLC grew its holdings in shares of UnitedHealth Group by 11.8% during the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock worth $19,210,000 after buying an additional 4,022 shares in the last quarter. Mitchell & Pahl Private Wealth LLC lifted its stake in UnitedHealth Group by 0.4% in the 4th quarter. Mitchell & Pahl Private Wealth LLC now owns 8,826 shares of the healthcare conglomerate’s stock valued at $4,465,000 after acquiring an additional 39 shares in the last quarter. Finally, Pure Financial Advisors LLC grew its stake in shares of UnitedHealth Group by 2.9% during the 4th quarter. Pure Financial Advisors LLC now owns 3,674 shares of the healthcare conglomerate’s stock worth $1,858,000 after acquiring an additional 102 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

UNH stock opened at $524.78 on Wednesday. The company’s 50-day moving average price is $547.07 and its two-hundred day moving average price is $563.84. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $482.95 billion, a P/E ratio of 33.86, a P/E/G ratio of 1.38 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the company earned $5.83 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Analyst Ratings Changes

A number of research analysts recently weighed in on UNH shares. Bank of America decreased their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Oppenheimer upped their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. KeyCorp reiterated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, Barclays decreased their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Two analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.